Diprivan Supplier Beefs Up AstraZeneca Contract Suit

Law360, New York (January 25, 2010, 1:51 PM EST) -- The chemical company that provides AstraZeneca UK Ltd. with the active ingredient for its anesthetic and sedative Diprivan has tacked breach of contract allegations onto its suit seeking declaratory judgment that the parties' 2008 supply agreement is valid and enforceable.

Albemarle Corp. lodged its amended complaint in the U.S. District Court for the District of South Carolina on Friday, adding two claims pertaining to the drugmaker's own breach of contract lawsuit currently pending in English court that allegedly violates the disputed contract's forum selection clause, which...
To view the full article, register now.